LONDON--(BUSINESS WIRE)--Technavio has been monitoring the global drug eluting balloons (DEBs) market size and it is poised to grow by USD 476.64 million during 2020-2024, progressing at a CAGR of almost 13% during the forecast period. The report offers an up-to-date analysis regarding the current market scenario, latest trends and drivers, and the overall market environment.
Although the COVID-19 pandemic continues to transform the growth of various industries, the immediate impact of the outbreak is varied. While a few industries will register a drop in demand, numerous others will continue to remain unscathed and show promising growth opportunities. Technavio’s in-depth research has all your needs covered as our research reports include all foreseeable market scenarios, including pre- & post-COVID-19 analysis. Download a Free Sample Report on COVID-19 Impacts
Frequently Asked Questions:
-
What was the size of the drug eluting balloons (DEBs) market in 2019?
As per Technavio, the global market size was USD 591.05 million in 2019 and is poised to reach USD 1067.69 million by 2024. -
Based on segmentation by product, which is the leading segment in the market?
Peripheral DEBs segment is leading the global DEBs market. -
At what rate is the market projected to grow?
Growing at a CAGR of almost 13%, the market growth will accelerate during the forecast period of 2020-2024. -
Who are the top players in the market?
B. Braun Melsungen AG, Becton, Dickinson and Co., BIOTRONIK SE & Co. KG, Boston Scientific Corp., Cardinal Health Inc., Cardionovum GmbH, COOK MEDICAL LLC, Koninklijke Philips NV, Medtronic Plc, and Opto Circuits (India) Ltd. are some of the major market participants. -
What are the key market drivers and challenges?
Growing demand for cath labs has been instrumental in driving the growth of the market. However, the stringent regulatory process might hamper the market growth. -
How big is the North American market?
The DEBs market in North America was valued at USD 265.97 million in 2019.
The market is concentrated, and the degree of concentration will accelerate during the forecast period. B. Braun Melsungen AG, Becton, Dickinson and Co., BIOTRONIK SE & Co. KG, Boston Scientific Corp., Cardinal Health Inc., Cardionovum GmbH, COOK MEDICAL LLC, Koninklijke Philips NV, Medtronic Plc, and Opto Circuits (India) Ltd. are some of the major market participants. To make the most of the opportunities, market vendors should focus more on the growth prospects in the fast-growing segments, while maintaining their positions in the slow-growing segments.
Buy 1 Technavio report and get the second for 50% off. Buy 2 Technavio reports and get the third for free.
View market snapshot before purchasing
The growing demand for cath labs has been instrumental in driving the growth of the market. However, the stringent regulatory process might hamper the market growth.
Technavio's custom research reports offer detailed insights on the impact of COVID-19 at an industry level, a regional level, and subsequent supply chain operations. This customized report will also help clients keep up with new product launches in direct & indirect COVID-19 related markets, upcoming vaccines and pipeline analysis, and significant developments in vendor operations and government regulations.
Drug Eluting Balloons (DEBs) Market 2020-2024: Segmentation
Drug Eluting Balloons (DEBs) Market is segmented as below:
-
Product
- Peripheral DEBs
- Coronary DEBs
-
Geographic Landscape
- North America
- Europe
- Asia
- ROW
To learn more about the global trends impacting the future of market research, download a free sample: https://www.technavio.com/talk-to-us?report=IRTNTR43398
Drug Eluting Balloons (DEBs) Market 2020-2024: Scope
Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources. The drug eluting balloons (DEBs) market report covers the following areas:
- Drug Eluting Balloons (DEBs) Market Size
- Drug Eluting Balloons (DEBs) Market Trends
- Drug Eluting Balloons (DEBs) Market Industry Analysis
This study identifies favorable reimbursement policies as one of the prime reasons driving the drug eluting balloons (DEBs) market growth during the next few years.
Technavio suggests three forecast scenarios (optimistic, probable, and pessimistic) considering the impact of COVID-19. Technavio’s in-depth research has direct and indirect COVID-19 impacted market research reports.
Register for a free trial today and gain instant access to 17,000+ market research reports.
Technavio's SUBSCRIPTION platform
Drug Eluting Balloons (DEBs) Market 2020-2024: Key Highlights
- CAGR of the market during the forecast period 2020-2024
- Detailed information on factors that will assist drug eluting balloons (DEBs) market growth during the next five years
- Estimation of the drug eluting balloons (DEBs) market size and its contribution to the parent market
- Predictions on upcoming trends and changes in consumer behavior
- The growth of the drug eluting balloons (DEBs) market
- Analysis of the market’s competitive landscape and detailed information on vendors
- Comprehensive details of factors that will challenge the growth of drug eluting balloons (DEBs) market, vendors
Table of Contents:
Executive Summary
Market Landscape
- Market ecosystem
- Value chain analysis
Market Sizing
- Market definition
- Market segment analysis
- Market size 2019
- Market outlook: Forecast for 2019 - 2024
Five Forces Analysis
- Five Force Summary
- Bargaining power of buyers
- Bargaining power of suppliers
- Threat of new entrants
- Threat of substitutes
- Threat of rivalry
- Market condition
Market Segmentation by Product
- Market segments
- Comparison by Product
- Peripheral DEBs - Market size and forecast 2019-2024
- Coronary DEBs - Market size and forecast 2019-2024
- Market opportunity by Product
Market Segmentation by End-user
- Cath labs
- Hospitals
- Ambulatory surgery centers (ASCs)
Customer Landscape
Geographic Landscape
- Geographic segmentation
- Geographic comparison
- North America - Market size and forecast 2019-2024
- Europe - Market size and forecast 2019-2024
- Asia - Market size and forecast 2019-2024
- ROW - Market size and forecast 2019-2024
- Key leading countries
- Market opportunity by geography
Volume Driver – demand led growth
Market Challenges
Market Trends
Vendor Landscape
- Vendor landscape
- Landscape disruption
- Competitive scenario
Vendor Analysis
- Vendors covered
- Market positioning of vendors
- B. Braun Melsungen AG
- BIOTRONIK SE & Co. KG
- Boston Scientific Corp.
- Cardinal Health Inc.
- Cardionovum GmbH
- COOK MEDICAL LLC
- Koninklijke Philips NV
- Medtronic Plc
- Opto Circuits (India) Ltd.
Appendix
- Scope of the report
- Currency conversion rates for US$
- Research methodology
- List of abbreviations
About Us
Technavio is a leading global technology research and advisory company. Their research and analysis focuses on emerging market trends and provides actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions. With over 500 specialized analysts, Technavio’s report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio’s comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.